Treatment of Clostridium difficile-associated disease: old therapies and new strategies
Top Cited Papers
- 1 September 2005
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 5 (9), 549-557
- https://doi.org/10.1016/s1473-3099(05)70215-2
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoeaJournal of Antimicrobial Chemotherapy, 2004
- A double-‘blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in aids patients in MexicoTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Financial burden of hospital-acquired Clostridium difficile infectionJournal of Hospital Infection, 1996
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxinThe Journal of Pediatrics, 1991
- Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophoreCellular Immunology, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Epidemiology and prevention ofClostridium difficile infections in a leukemia unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Treatment of relapsingClostridium difficile diarrhoea by administration of a non-toxigenic strainEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978
- STAPHYLOCOCCAL PSEUDOMEMBRANOUS ENTEROCOLITIS COMPLICATING TREATMENT WITH AUREOMYCINThe Lancet, 1954